RANCHO CUCAMONGA, CA / ACCESSWIRE / May 2, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release…
BALTIMORE, MD / ACCESSWIRE / May 2, 2022 / Univec, Inc. (OTCMarktets:UNVC) a mental health and substance abuse total wraparound…
KITCHENER, ON / ACCESSWIRE / May 2, 2022 / Cloud DX (TSXV:CDX) (OTCQB:CDXFF), (the "Company") a leading North American provider…
Need an expert commentator on grief, trauma and burnout?Meet Sherry Walling, MAT, PhDMINNEAPOLIS, MN / ACCESSWIRE / May 2, 2022…
WHITE PLAINS, NY / ACCESSWIRE / May 2, 2022 / Hospice of Westchester (HOW) has voted in new officers and…
Collaboration with HealCommunity Offers Remote Access to Reimbursable Group Therapy OptionTORONTO, ON / ACCESSWIRE / May 2, 2022 / Novamind…
LAS VEGAS, NV / ACCESSWIRE / May 2, 2022 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"),a…
– Experienced oncology drug developer with more than two decades advancing treatments for solid tumors and hematologic malignancies joins Codiak leadership…
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company…
The Phase I safety and pharmacokinetic study in 24 healthy volunteers has completed enrollment. The study is still blinded, but…